DEFINITIVE PROXY STATEMENT

Company

Inhibitor Therapeutics, Inc.

Filed

April 9, 2001

Period of Report

December 31, 2000

Accession Number

0000916641-01-000531

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →